簡易檢索 / 詳目顯示
| 研究生： |
楊修 Yang, Hsiu |
|---|---|
| 論文名稱： |
延續性效應對平均生物等效性之影響的研究 |
| 指導教授： | 蔡碧紋 |
| 學位類別： |
碩士 Master |
| 系所名稱： |
數學系 Department of Mathematics |
| 論文出版年： | 2019 |
| 畢業學年度： | 107 |
| 語文別： | 中文 |
| 論文頁數： | 35 |
| 中文關鍵詞： | 平均生物等效性 、延續性效應 、Westlake法 、貝氏法 、信賴區間法 、雙單側檢定法 |
| DOI URL： | http://doi.org/10.6345/NTNU201900903 |
| 論文種類： | 學術論文 |
| 相關次數： | 點閱：102 下載：14 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
生物等效性試驗是指用生物利用度研究的方法，以藥物動力參數為指標，比較兩種藥物在相同的試驗條件下，其活性成分在人體中吸收程度和速度是否存在統計學差異。本文研究目的是探討在兩週期交叉試驗設計生物等效性研究，相對延續性效應和變異係數對平均生物等效性判定的影響。其中我們以模擬分析四種常見的判定方法：Westlake 方法 ,貝氏法,信賴區間法, 雙單側檢定法。在當兩種藥物具有平均生物等效性和不具有平均生物等效性的情況下，分析在不同樣本數，不同相對性延續性效應和變異係數下這四種方法的生物等效性聲明百分比的變化。
Box, E.P. and Tiao, C.(1973). Bayesian inference in statistical analysis. Addison-Wesley Publishing.
Fluehler, H. and Hirtz, J. and Moser, H.(1981). An Aid to Decision marking in Bioequivalence Assessment. Jpharmacokinet Biopharm,9, Pages 235-243
Fluehler, H. and Grieve, A.P. and Mau, J. and Moser, H.A.(1983). Bayesian approach to bioequivalenceassessment: An example. Volume ,72,10, Pages 1178–1181.
Grizzle, J.E.(1965). The Two-Period Change-Over Design and Its Use in Clinical Trials.Biometrics,21, Pages 467-480.
Jordi, O. and Pilar, M.S and Alex, S. and Josep, L.C.(2008).On equivalence and bioequivalence testing.SORT,32, Pages 151-176.
Mandallz, D. and Mau, J.(1981).Comparison of different methods for decision-making in bioequivalence assessment. Biometrics,37, Pages 213-222.
Murray, R.S. and P.Dempster. and Nancy,R.H.(1981). A Bayesian Approach to Bioequivalence for the 2 x 2 Changeover Design.Biometrics,37, Pages 11-21.
Roger, L.B. and Jason, C.H.(1995). Bioequivalence Trials,Intersection Union Tests, and Equivalence Confidence Sets.Statistical and Science, Pages 283-319.
Rain, S. and Pargal, A.(2004). Bioequivalence: An overview of statistical concepts.Journal Pharmacology,36, Pages 209-216.
Schuirmann, D.L.(1981). On Hypothesis Testing to Determine If the Mean of a Normal Distribution Is Contained in a Known Interval.Biometrics,37,Pages 617.
Steinijans, V.W. and Diletti, E.(1983). Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals.Clin Pharmaco,l24, Pages 127-136.
Schuirmann, D.J.(1987). A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability.Journal of Pharmacokinetics and Biopharmaceutics,15, Pages 657-680.
Sanchez, M.P. and Ocana, J. and Carrasco, J.L.(2011). The effect of variability and carryover on average bioequivalence assessment: a simulation study.Pharm Stat,2,
Pages 35-42.
Westlake, W.J.(1972). Use of confidence intervals in analysis of comparative bioavailability trials.J pharm Sci,8, Pages 340-341.
Westlake, W.J.(1976). Symmetrical Confidence Intervals for Bioequivalence Trials .Biometrics,32, Pages 741-744.
Westlake, W.J.(1981). Inresponse to kirkwood TBL Bioequivalence testing: A need to retbink.Biometrics,37, Pages 589-594.
Walter, W.H. and Sharon,A.(1983).A New Statistical Procedure for Testing Equivalence in Two-Group Comparative Bioavailability Trials.
